Search Results - "Shishir Maithel"

Refine Results
  1. 1
  2. 2
  3. 3

    Frailty and cancer: Implications for oncology surgery, medical oncology, and radiation oncology by Ethun, Cecilia G., Bilen, Mehmet A., Jani, Ashesh B., Maithel, Shishir K., Ogan, Kenneth, Master, Viraj A.

    Published in CA: a cancer journal for clinicians (01-09-2017)
    “…Answer questions and earn CME/CNE The concept of frailty has become increasingly recognized as one of the most important issues in health care and health…”
    Get full text
    Journal Article
  4. 4

    Adjuvant Therapy for Resected Biliary Tract Cancer: ASCO Clinical Practice Guideline by Shroff, Rachna T, Kennedy, Erin B, Bachini, Melinda, Bekaii-Saab, Tanios, Crane, Christopher, Edeline, Julien, El-Khoueiry, Anthony, Feng, Mary, Katz, Matthew H G, Primrose, John, Soares, Heloisa P, Valle, Juan, Maithel, Shishir K

    Published in Journal of clinical oncology (20-04-2019)
    “…To develop an evidence-based clinical practice guideline to assist in clinical decision making for patients with resected biliary tract cancer. ASCO convened…”
    Get full text
    Journal Article
  5. 5

    The Landmark Series: Gallbladder Cancer by Gamboa, Adriana C., Maithel, Shishir K.

    Published in Annals of surgical oncology (01-08-2020)
    “…Given the rarity of gallbladder carcinoma, level I evidence to guide the multimodal treatment of this disease is lacking. Since 2010, four randomized phase III…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    Gallbladder cancer by Roa, Juan C., García, Patricia, Kapoor, Vinay K., Maithel, Shishir K., Javle, Milind, Koshiol, Jill

    Published in Nature reviews. Disease primers (27-10-2022)
    “…Gallbladder cancer (GBC) is the most common cancer of the biliary tract, characterized by a very poor prognosis when diagnosed at advanced stages owing to its…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11
  12. 12

    In Patients with Localized and Resectable Gastric Cancer, What is the Optimal Extent of Lymph Node Dissection—D1 Versus D2 Versus D3? by Mogal, Harveshp, Fields, Ryan, Maithel, Shishir K., Votanopoulos, Konstantinos

    Published in Annals of surgical oncology (01-09-2019)
    “…Background Despite advances in the treatment of patients with gastric cancer, the debate over the optimal extent of lymphadenectomy continues. Method A review…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15
  16. 16

    Management of Lymph Nodes During Resection of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: A Systematic Review by Amini, Neda, Ejaz, Aslam, Spolverato, Gaya, Maithel, Shishir K., Kim, Yuhree, Pawlik, Timothy M.

    Published in Journal of gastrointestinal surgery (01-12-2014)
    “…The role of lymph node dissection (LND) in the treatment of patients with hepatocellular carcinoma (HCC) or intrahepatic cholangiocarcinoma (ICC) remains…”
    Get full text
    Journal Article
  17. 17
  18. 18

    A Review of the Indications, Outcomes, and Postoperative Management After Total and Completion Pancreatectomy for Pancreatic Cancer: More Is Not Necessarily Better by Oppat, Kailey M, Bennett, Frances J, Maithel, Shishir K

    Published in The Surgical clinics of North America (01-10-2024)
    “…With improvements in surgical technique and advances in pancreatic endocrine and exocrine replacement therapy, the indications for, and threshold to perform,…”
    Get full text
    Journal Article
  19. 19
  20. 20